Table 3. Site/Source of infection.
| Community onset (n = 143)* | ||||
|---|---|---|---|---|
| Site/source of infection n(%) | Overall (n = 201) | Community acquired (n = 83) | Healthcare associated (n = 57) | Hospital acquired (n = 58) |
| CNS | 6 (3%) | 6 (7%) | 0 (0%) | 0 (0%) |
| Endocarditis | 3 (1%) | 2 (2%) | 1 (2%) | 0 (0%) |
| Mediastinitis | 1 (0%) | 0 (0%) | 0 (0%) | 1 (2%) |
| Musculoskeletal | 28 (14%) | 21 (25%) | 5 (9%) | 2 (3%) |
| Pulmonary | 5 (2%) | 5 (6%) | 0 (0%) | 0 (0%) |
| SST | 29 (14%) | 20 (24%) | 5 (9%) | 4 (7%) |
| Unknown | 46 (23%) | 29 (35%) | 6 (11%) | 8 (14%) |
| Vascular | 83 (41%) | 0 (0%) | 40 (70%) | 43 (74%) |
*Of the 143 community onset cases, 3 were not classified into healthcare associated or community acquired due to inadequate documentation in the medical record.
CNS, central nervous system
SST, skin and soft tissue